Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The worldwide Pirfenidone market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 4.0% during the forecast period.
This report presents the market size and development trends by detailing the Pirfenidone market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Pirfenidone market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Pirfenidone industry and will help you to build a panoramic view of the industrial development.
Pirfenidone Market, By Type:
Tablet
Capsule
Other
Pirfenidone Market, By Application:
Mild Idiopathic Pulmonary Fibrosis
Moderate Idiopathic Pulmonary Fibrosis
Other
Some of the leading players are as follows:
Beijing Continent
GNI Group
Lupin Ltd
Incepta Pharmaceuticals
Unimed Unihealth
Shionogi
Glenmark Pharmaceuticals
Genentech (Roche)
Wockhardt
Zydus Cadila
Cipla
MSN Laboratories
Koye Pharmaceuticals
Geographically, Major regions are analyzed in details are as follows:
-
North America
-
Europe
-
Asia Pacific
-
Latin America
-
Middle East & Africa
Table of Contents
1 Methodology and Scope
-
1.1 Market Segmentation & Scope
-
1.1.1 Technology Type
-
1.1.2 Product
-
1.1.3 Application
-
1.1.4 Regional scope
-
1.1.5 Estimates and forecast timeline
-
1.2 Research Methodology
-
1.3 Information Procurement
-
1.3.1 Purchased database
-
1.3.2 Internal database
-
1.3.3 Secondary sources
-
1.3.4 Primary research
-
1.3.5 Details of primary research
-
1.4 Information or Data Analysis
-
1.4.1 Data analysis models
-
1.5 Market Formulation & Validation
-
1.6 Model Details
-
1.6.1 Commodity flow analysis
-
1.6.2 Volume price analysis
-
1.7 List of Secondary Sources
-
1.8 List of Abbreviations
2 Executive Summary
-
2.1 Market Outlook
-
2.2 Segment Outlook
3 Market Variables, Trends, & Scope
-
3.1 Market Lineage Outlook
-
3.1.1 Parent market outlook
-
3.1.2 Ancillary market outlook
-
3.2 Market Segmentation
-
3.2.1 Analysis
-
3.3 Market Dynamics
-
3.3.1 Market driver analysis
-
3.3.2 Market restraint analysis
-
3.3.3 Industry opportunities
-
3.4 Penetration & Growth Prospect Mapping
-
3.4.1 Penetration & growth prospect mapping analysis
-
3.5 Business Environment Analysis Tools
-
3.5.1 Porter's five forces analysis
-
3.5.2 PESTLE analysis
-
3.5.3 Major deals & strategic alliances analysis
4 Pirfenidone Market: Technology Type Analysis
-
4.1 Pirfenidone Technology Type Market Share Analysis, 2018 & 2026
-
4.2 Pirfenidone Technology Type Market: Segment Dashboard
-
4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment
4.3.1 Tablet
4.3.2 Capsule
4.3.3 Other
5 Pirfenidone Market: Product Analysis
-
5.1 Pirfenidone Product Market Share Analysis, 2018 & 2026
-
5.2 Pirfenidone Product Market: Segment Dashboard
-
5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment
6 Pirfenidone Market: Application Analysis
-
6.1 Pirfenidone Application Market Share Analysis, 2018 & 2026
-
6.2 Pirfenidone Application Market: Segment Dashboard
-
6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment
6.3.1 Mild Idiopathic Pulmonary Fibrosis
6.3.2 Moderate Idiopathic Pulmonary Fibrosis
6.3.3 Other
7 Pirfenidone Market: Regional Analysis
-
7.1 Pirfenidone Regional Market Share Analysis, 2018 & 2026
-
7.2 Pirfenidone Regional Market: Segment Dashboard
-
7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)
-
7.4 List of Players at Regional Level
-
7.4.1 North America
-
7.4.2 Europe
-
7.4.3 Asia Pacific
-
7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
-
7.5.1 North America
-
7.5.2 Europe
-
7.5.3 Asia Pacific
-
7.5.4 Latin America
-
7.5.5 MEA
-
7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026
-
7.6.1 North America
-
7.6.2 Europe
-
7.6.3 Asia Pacific
-
7.6.4 Latin America
-
7.6.5 Middle East & Africa
8 Competitive Analysis
-
8.1 Recent Developments & Impact Analysis, by Key Market Participants
-
8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)
-
8.3 Vendor Landscape
-
8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)
9 Company Profiles
9.1 Beijing Continent
9.1.1 Beijing Continent Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.1.5 SWOT analysis
9.2 GNI Group
9.2.1 GNI Group Company overview
9.2.2 Financial performance
9.2.3 Product benchmarking
9.2.4 Strategic initiatives
9.2.5 SWOT analysis
9.3 Lupin Ltd
9.3.1 Lupin Ltd Company overview
9.3.2 Financial performance
9.3.3 Product benchmarking
9.3.4 Strategic initiatives
9.3.5 SWOT analysis
9.4 Incepta Pharmaceuticals
9.4.1 Incepta Pharmaceuticals Company overview
9.4.2 Financial performance
9.4.3 Product benchmarking
9.4.4 Strategic initiatives
9.4.5 SWOT analysis
9.5 Unimed Unihealth
9.5.1 Unimed Unihealth Company overview
9.5.2 Financial performance
9.5.3 Product benchmarking
9.5.4 Strategic initiatives
9.5.5 SWOT analysis
9.6 Shionogi
9.6.1 Shionogi Company overview
9.6.2 Financial performance
9.6.3 Product benchmarking
9.6.4 Strategic initiatives
9.6.5 SWOT analysis
9.7 Glenmark Pharmaceuticals
9.7.1 Glenmark Pharmaceuticals Company overview
9.7.2 Financial performance
9.7.3 Product benchmarking
9.7.4 Strategic initiatives
9.7.5 SWOT analysis
9.8 Genentech (Roche)
9.8.1 Genentech (Roche) Company overview
9.8.2 Financial performance
9.8.3 Product benchmarking
9.8.4 Strategic initiatives
9.8.5 SWOT analysis
9.9 Wockhardt
9.9.1 Wockhardt Company overview
9.9.2 Financial performance
9.9.3 Product benchmarking
9.9.4 Strategic initiatives
9.9.5 SWOT analysis
9.10 Zydus Cadila
9.10.1 Zydus Cadila Company overview
9.10.2 Financial performance
9.10.3 Product benchmarking
9.10.4 Strategic initiatives
9.10.5 SWOT analysis
9.11 Cipla
9.11.1 Cipla Company overview
9.11.2 Financial performance
9.11.3 Product benchmarking
9.11.4 Strategic initiatives
9.11.5 SWOT analysis
9.12 MSN Laboratories
9.12.1 MSN Laboratories Company overview
9.12.2 Financial performance
9.12.3 Product benchmarking
9.12.4 Strategic initiatives
9.12.5 SWOT analysis
9.13 Koye Pharmaceuticals
9.13.1 Koye Pharmaceuticals Company overview
9.13.2 Financial performance
9.13.3 Product benchmarking
9.13.4 Strategic initiatives
9.13.5 SWOT analysis
The List of Tables and Figures (Totals 101 Figures and 157 Tables)
Figure Tablet Pirfenidone market, 2015 - 2026 (USD Million)
Figure Capsule Pirfenidone market, 2015 - 2026 (USD Million)
Figure Other Pirfenidone market, 2015 - 2026 (USD Million)
Figure Mild Idiopathic Pulmonary Fibrosis market, 2015 - 2026 (USD Million)
Figure Moderate Idiopathic Pulmonary Fibrosis market, 2015 - 2026 (USD Million)
Figure Other market, 2015 - 2026 (USD Million)
-
Table List of players in North America
-
Table List of players in Europe
-
Table List of players in Asia Pacific
-
Table SWOT analysis
-
Table North America Pirfenidone market, by country, 2015 - 2026 (USD Million)
-
Table North America Pirfenidone market, by type, 2015 - 2026 (USD Million)
-
Table North America Pirfenidone market, by product, 2015 - 2026 (USD Million)
-
Table North America Pirfenidone market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.S. Pirfenidone market, by type, 2015 - 2026 (USD Million)
-
Table U.S. Pirfenidone market, by product, 2015 - 2026 (USD Million)
-
Table U.S. Pirfenidone market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Canada Pirfenidone market, by type, 2015 - 2026 (USD Million)
-
Table Canada Pirfenidone market, by product, 2015 - 2026 (USD Million)
-
Table Canada Pirfenidone market, by application, 2015 - 2026 (USD Million)
-
Table Europe Pirfenidone market, by country, 2015 - 2026 (USD Million)
-
Table Europe Pirfenidone market, by type, 2015 - 2026 (USD Million)
-
Table Europe Pirfenidone market, by product, 2015 - 2026 (USD Million)
-
Table Europe Pirfenidone market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.K. Pirfenidone market, by type, 2015 - 2026 (USD Million)
-
Table U.K. Pirfenidone market, by product, 2015 - 2026 (USD Million)
-
Table U.K. Pirfenidone market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Germany Pirfenidone market, by type, 2015 - 2026 (USD Million)
-
Table Germany Pirfenidone market, by product, 2015 - 2026 (USD Million)
-
Table Germany Pirfenidone market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table France Pirfenidone market, by type, 2015 - 2026 (USD Million)
-
Table France Pirfenidone market, by product, 2015 - 2026 (USD Million)
-
Table France Pirfenidone market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Italy Pirfenidone market, by type, 2015 - 2026 (USD Million)
-
Table Italy Pirfenidone market, by product, 2015 - 2026 (USD Million)
-
Table Italy Pirfenidone market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Spain Pirfenidone market, by type, 2015 - 2026 (USD Million)
-
Table Spain Pirfenidone market, by product, 2015 - 2026 (USD Million)
-
Table Spain Pirfenidone market, by application, 2015 - 2026 (USD Million)
-
Table Asia Pacific Pirfenidone market, by country, 2015 - 2026 (USD Million)
-
Table Asia Pacific Pirfenidone market, by type, 2015 - 2026 (USD Million)
-
Table Asia Pacific Pirfenidone market, by product, 2015 - 2026 (USD Million)
-
Table Asia Pacific Pirfenidone market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table China Pirfenidone market, by type, 2015 - 2026 (USD Million)
-
Table China Pirfenidone market, by product, 2015 - 2026 (USD Million)
-
Table China Pirfenidone market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Japan Pirfenidone market, by type, 2015 - 2026 (USD Million)
-
Table Japan Pirfenidone market, by product, 2015 - 2026 (USD Million)
-
Table Japan Pirfenidone market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table India Pirfenidone market, by type, 2015 - 2026 (USD Million)
-
Table India Pirfenidone market, by product, 2015 - 2026 (USD Million)
-
Table India Pirfenidone market, by application, 2015 - 2026 (USD Million)
-
Table Latin America Pirfenidone market, by country, 2015 - 2026 (USD Million)
-
Table Latin America Pirfenidone market, by type, 2015 - 2026 (USD Million)
-
Table Latin America Pirfenidone market, by product, 2015 - 2026 (USD Million)
-
Table Latin America Pirfenidone market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Brazil Pirfenidone market, by type, 2015 - 2026 (USD Million)
-
Table Brazil Pirfenidone market, by product, 2015 - 2026 (USD Million)
-
Table Brazil Pirfenidone market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Mexico Pirfenidone market, by type, 2015 - 2026 (USD Million)
-
Table Mexico Pirfenidone market, by product, 2015 - 2026 (USD Million)
-
Table Mexico Pirfenidone market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Argentina Pirfenidone market, by type, 2015 - 2026 (USD Million)
-
Table Argentina Pirfenidone market, by product, 2015 - 2026 (USD Million)
-
Table Argentina Pirfenidone market, by application, 2015 - 2026 (USD Million)
-
Table MEA Pirfenidone market, by country, 2015 - 2026 (USD Million)
-
Table MEA Pirfenidone market, by type, 2015 - 2026 (USD Million)
-
Table MEA Pirfenidone market, by product, 2015 - 2026 (USD Million)
-
Table MEA Pirfenidone market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table South Africa Pirfenidone market, by type, 2015 - 2026 (USD Million)
-
Table South Africa Pirfenidone market, by product, 2015 - 2026 (USD Million)
-
Table South Africa Pirfenidone market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Nigeria Pirfenidone market, by type, 2015 - 2026 (USD Million)
-
Table Nigeria Pirfenidone market, by product, 2015 - 2026 (USD Million)
-
Table Nigeria Pirfenidone market, by application, 2015 - 2026 (USD Million)
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Company market position analysis
Table Company Profiles
Table Beijing Continent Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table GNI Group Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Lupin Ltd Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Incepta Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Unimed Unihealth Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Shionogi Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Glenmark Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Genentech (Roche) Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Wockhardt Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Zydus Cadila Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Cipla Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table MSN Laboratories Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Koye Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
-
